Free Trial

Concord Medical Services (CCM) Competitors

Concord Medical Services logo
$7.81 -0.65 (-7.68%)
Closing price 05/21/2025 03:59 PM Eastern
Extended Trading
$7.90 +0.09 (+1.09%)
As of 05/21/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CCM vs. CORBF, XGN, QIPT, SERA, BMGL, ATPC, KDLY, PIII, BDSX, and OPGN

Should you be buying Concord Medical Services stock or one of its competitors? The main competitors of Concord Medical Services include Global Cord Blood (CORBF), Exagen (XGN), Quipt Home Medical (QIPT), Sera Prognostics (SERA), Basel Medical Group (BMGL), Agape ATP (ATPC), Kindly MD (KDLY), P3 Health Partners (PIII), Biodesix (BDSX), and OpGen (OPGN). These companies are all part of the "healthcare" industry.

Concord Medical Services vs.

Concord Medical Services (NYSE:CCM) and Global Cord Blood (NYSE:CORBF) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, community ranking, risk, profitability, valuation, dividends, institutional ownership, earnings and media sentiment.

Company Net Margins Return on Equity Return on Assets
Concord Medical ServicesN/A N/A N/A
Global Cord Blood N/A N/A N/A

Global Cord Blood has lower revenue, but higher earnings than Concord Medical Services.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Concord Medical Services$383.96M0.09-$41.93MN/AN/A
Global Cord Blood$196.12M0.34$79.04MN/AN/A

In the previous week, Concord Medical Services' average media sentiment score of 0.64 beat Global Cord Blood's score of 0.00 indicating that Concord Medical Services is being referred to more favorably in the media.

Company Overall Sentiment
Concord Medical Services Positive
Global Cord Blood Neutral

Concord Medical Services received 197 more outperform votes than Global Cord Blood when rated by MarketBeat users.

CompanyUnderperformOutperform
Concord Medical ServicesOutperform Votes
197
58.28%
Underperform Votes
141
41.72%
Global Cord BloodN/AN/A

Concord Medical Services has a beta of -0.84, indicating that its share price is 184% less volatile than the S&P 500. Comparatively, Global Cord Blood has a beta of -0.68, indicating that its share price is 168% less volatile than the S&P 500.

Summary

Concord Medical Services and Global Cord Blood tied by winning 3 of the 6 factors compared between the two stocks.

Get Concord Medical Services News Delivered to You Automatically

Sign up to receive the latest news and ratings for CCM and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CCM vs. The Competition

MetricConcord Medical ServicesOffices & clinics of medical doctors IndustryMedical SectorNYSE Exchange
Market Cap$33.91M$1.78B$5.38B$19.42B
Dividend YieldN/AN/A5.21%3.83%
P/E RatioN/A29.9226.8034.23
Price / Sales0.091.58389.5534.85
Price / CashN/A36.0138.2517.51
Price / Book0.1416.426.804.69
Net Income-$41.93M-$52.07M$3.23B$1.02B
7 Day Performance0.13%0.25%1.53%-1.74%
1 Month Performance70.52%45.17%10.05%7.46%
1 Year Performance52.88%75.85%16.75%3.96%

Concord Medical Services Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CCM
Concord Medical Services
0.6399 of 5 stars
$7.81
-7.7%
N/A+20.1%$33.91M$383.96M0.00970Analyst Forecast
CORBF
Global Cord Blood
N/A$1.05
-3.7%
N/A-56.0%$127.63M$196.12M0.001,200
XGN
Exagen
4.5226 of 5 stars
$5.77
+1.1%
$7.50
+30.0%
+203.7%$103.87M$56.72M-6.14220Analyst Revision
QIPT
Quipt Home Medical
1.6768 of 5 stars
$2.13
-2.3%
$6.25
+193.4%
-38.7%$91.78M$244.72M-12.53800News Coverage
SERA
Sera Prognostics
1.2218 of 5 stars
$2.32
+4.5%
N/A-77.0%$87.38M$77,000.00-2.34120Positive News
BMGL
Basel Medical Group
N/A$4.70
-1.7%
N/AN/A$86.74M$10.05M0.0036Gap Down
High Trading Volume
ATPC
Agape ATP
0.4253 of 5 stars
$1.65
+5.8%
N/A-59.3%$82.51M$1.32M-2.2640Earnings Report
KDLY
Kindly MD
1.0912 of 5 stars
$13.69
+251.0%
N/AN/A$82.44M$2.72M-17.78N/ANews Coverage
Gap Up
High Trading Volume
PIII
P3 Health Partners
2.2082 of 5 stars
$8.45
-3.0%
$16.25
+92.3%
-70.6%$60.69M$1.50B-10.06500Earnings Report
Gap Down
BDSX
Biodesix
3.2848 of 5 stars
$0.36
-3.3%
$2.83
+686.0%
-74.8%$52.63M$71.32M-0.92220Analyst Forecast
Gap Up
High Trading Volume
OPGN
OpGen
N/A$4.95
+0.8%
N/A+41.0%$41.03M$2.67M0.00100News Coverage
Analyst Forecast

Related Companies and Tools


This page (NYSE:CCM) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners